| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;47:14.)
© 2006 American Heart Association, Inc.
Editorial Commentaries |
From the Section of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington.
Correspondence to William B. White, M.D., Professor of Medicine, Section of Hypertension and Clinical Pharmacology, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT 06030. E-mail: wwhite@nso1.uchc.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
For patients with hypertension and their physicians who care for them, assessment of blood pressure (BP) over 24 hours with an automated monitor has considerable appeal. When done properly, ambulatory BP recordings yield far more reproducible values over fairly long periods of time compared with the doctors office BP.1 Because ambulatory BP monitoring yields multiple readings during all of a patients activities, including the sleeping period and time at work, this method gives a more comprehensive representation of the vascular burden of hypertension than a small number of BP readings in the office of a clinician.2,3 In fact, recent analyses of cohorts of patients with both untreated and treated hypertension followed for up to a decade have typically shown that ambulatory BP has better predictive values for future cardiovascular events than clinical measurements of BP.4,5
When the usefulness of ambulatory BP monitoring became recognized early on by hypertension specialists, the focus of its use was for the evaluation of white-coat hypertension. Unfortunately, the definition of white-coat hypertension has varied a great deal in the medical literature because of arbitrary differences between clinical measurements and various components of the ambulatory BP, such as 24-hour mean, daytime, or awake periods.6 The variability of the definition of white-coat hypertension in the prognostic studies and the duration of follow-up for cardiovascular outcomes has made direct comparisons among these studies difficult, if not impossible. Clearly though, the appropriate trend for defining white-coat hypertension in untreated patients has been to use lower out-of-office values, such as
This article has been cited by other articles:
![]() |
E. O'Brien Ambulatory Blood Pressure Measurement: The Case for Implementation in Primary Care Hypertension, June 1, 2008; 51(6): 1435 - 1441. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |